AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
+8.08%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$164M
AUM Growth
–
Cap. Flow
+$164M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IQVIA
IQV
|
$84.5M |
| 2 |
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
|
$40M |
| 3 |
CMRX
Chimerix, Inc.
CMRX
|
$18.5M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$9.4M |
| 5 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 68.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
IQVIA
IQV
$32.4B
| $84.5M | 51.65% | +1,823,575 | New | +$84.5M |
|
|
DRTX
2
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $40M | 24.45% | +3,130,824 | New | +$40M |
|
|
CMRX
3
DELISTED
Chimerix, Inc.
CMRX
| $18.5M | 11.31% | +1,222,943 | New | +$18.5M |
|
|
ICPT
4
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.4M | 5.75% | +137,519 | New | +$9.4M |
|
|
SRNE
5
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $5M | 3.06% | +620,700 | New | +$5M |
|